Tag: risk-based monitoring

Using RACT to Prioritize Sites, Data Streams and Quality Controls

November 17, 2025November 15, 2025 digi

Using RACT to Prioritize Sites, Data Streams and Quality Controls Using RACT to Prioritize Sites, Data Streams and Quality Controls This comprehensive guide serves as a detailed tutorial for clinical operations, regulatory affairs, and medical affairs professionals aiming to implement the Risk Assessment Categorization Tool (RACT) in the realm of risk-based monitoring (RBM). By systematically…

Risk Assessment Categorization Tool (RACT)

Risk Assessment Categorization Tool (RACT): Step-by-Step Guide for Study Teams

November 17, 2025November 15, 2025 digi

Risk Assessment Categorization Tool (RACT): Step-by-Step Guide for Study Teams Risk Assessment Categorization Tool (RACT): Step-by-Step Guide for Study Teams The Risk Assessment Categorization Tool (RACT) is an essential instrument in the realm of clinical trials, particularly in the context of risk-based monitoring (RBM). It enables clinical operations, regulatory affairs, and medical affairs professionals to…

Risk Assessment Categorization Tool (RACT)

Building a High-Impact RACT for Global Clinical Trials

November 17, 2025November 15, 2025 digi

Building a High-Impact RACT for Global Clinical Trials Building a High-Impact RACT for Global Clinical Trials In the ever-evolving landscape of clinical trials, dedicated tools are crucial for enhancing oversight and ensuring compliance with regulatory standards. One such tool is the Risk Assessment Categorization Tool (RACT), which is designed to identify and categorize risks associated…

Risk Assessment Categorization Tool (RACT)

Risk Based Monitoring in Site vs. Sponsor Perspectives: Aligning Operational and Oversight Expectations

November 14, 2025

Risk Based Monitoring in Site vs. Sponsor Perspectives: Aligning Operational and Oversight Expectations Aligning Site and Sponsor Perspectives on Risk Based Monitoring: Operational and Oversight Strategies for Global Clinical Trials Risk based monitoring (RBM) has become a cornerstone approach in modern clinical trial management, offering a data-driven method to optimize monitoring activities while ensuring subject…

Clinical Trial Fundamentals, Site vs. Sponsor Perspectives

Hybrid Transition & Change Management in DCTs: A Compliance-First Playbook (2025)

November 9, 2025November 14, 2025 digi

Hybrid Transition & Change Management in DCTs: A Compliance-First Playbook (2025) Managing Hybrid Transitions and Change With Regulatory Confidence Why Hybridization Now: Principles, Roles, and the Regulatory Frame Most sponsors do not leap from site-centric research to fully decentralized trials; the durable pattern is a hybrid operating model that blends on-site, in-home, and virtual procedures….

Decentralized & Hybrid Clinical Trials (DCTs), Hybrid Transition & Change Management

Data Integrity & Monitoring in DCTs: Making Every Number Click to Proof (2025)

November 9, 2025November 14, 2025 digi

Data Integrity & Monitoring in DCTs: Making Every Number Click to Proof (2025) Engineering Data Integrity and Risk-Based Monitoring for Decentralized Trials Principles, Roles, and the Global Compliance Frame for DCT Data Integrity Decentralized and hybrid trials distribute evidence creation across homes, phones, couriers, and community clinics. That dispersion does not dilute obligations to protect…

Data Integrity & Monitoring in DCTs, Decentralized & Hybrid Clinical Trials (DCTs)

Safety & Emergency Procedures at Home in DCTs: A Clinically Robust, Inspection-Ready Playbook (2025)

November 9, 2025November 14, 2025 digi

Safety & Emergency Procedures at Home in DCTs: A Clinically Robust, Inspection-Ready Playbook (2025) Managing Safety and Emergencies at Home Without Compromising Rigor Safety by Design: Principles, Roles, and the Global Compliance Frame In decentralized and hybrid clinical trials (DCTs), the clinical environment follows the participant—into living rooms, workplaces, pharmacies, and community clinics. That shift…

Decentralized & Hybrid Clinical Trials (DCTs), Safety & Emergency Procedures at Home

Regulatory Expectations for DCTs: What Inspectors Will Ask in 2025

November 8, 2025November 14, 2025 digi

Regulatory Expectations for DCTs: What Inspectors Will Ask in 2025 Meeting Regulator Expectations for Decentralized and Hybrid Trials The Compliance Frame: What “Good” Looks Like for DCTs Regulators evaluate decentralized and hybrid trials against a simple standard: the same scientific validity, participant protection, and data integrity expected at an on-site visit must be demonstrated when…

Decentralized & Hybrid Clinical Trials (DCTs), Regulatory Expectations for DCTs

Remote Consent & Identity Verification in DCTs: A Compliance-First Blueprint (2025)

November 8, 2025November 14, 2025 digi

Remote Consent & Identity Verification in DCTs: A Compliance-First Blueprint (2025) Remote Consent and Identity Verification That Withstand Regulatory Scrutiny Purpose, Principles, and the Global Frame for Remote Consent Decentralized and hybrid clinical trials (DCTs) move critical interactions—screening, consent discussions, and confirmation of participant identity—outside the clinic. Remote consent is not simply “signing online.” It…

Decentralized & Hybrid Clinical Trials (DCTs), Remote Consent & Identity Verification

Direct-to-Patient IP & Kitting: A Compliance-First Logistics Playbook (2025)

November 8, 2025November 14, 2025 digi

Direct-to-Patient IP & Kitting: A Compliance-First Logistics Playbook (2025) Designing Direct-to-Patient Logistics and Kitting That Withstand Inspection Purpose, Models, and the Global Compliance Frame Direct-to-patient (DtP) logistics move investigational products (IP/IMP), devices, and supplies from depots to participants’ doorsteps while preserving the same obligations that apply inside a pharmacy window: identity-aligned dispensing, temperature control, tamper…

Decentralized & Hybrid Clinical Trials (DCTs), Logistics: Direct-to-Patient IP & Kitting